News and Media

Latest News Release
01/31/2024

Transaction creates increased clinical and economic value for 11,500 specialty providers, including more than 7,000 physicians across 1,200 independent physician practices Transaction creates...

Top feature box IMAGE ONLY - COMPANY NEWS

Press Releases

Balance of Clinical Excellence and Cost-Effectiveness in Interventional Cardiology Focus for Cardinal Health
09/12/2014
Company to Host Physician Panel at Transcatheter Cardiovascular Therapeutics Event

DUBLIN, Ohio, Sept. 12, 2014 — In the current health care environment of steadily increasing costs and declining reimbursement, health systems are in search of innovative approaches to lower the total cost of care while maintaining high quality patient care. At the Cardiovascular Research Foundation Transcatheter Cardiovascular Therapeutics (TCT) event next week in Washington, D.C., Cardinal Health and physicians from leading healthcare institutions around the world will help interventionalists explore the balance between the two.

On Tuesday, Sept. 16, Cardinal Health Medical Segment CEO Don Casey will discuss health care industry business model innovation before joining co-chair Martin B. Leon, MD, from New York-Presbyterian Hospital/Columbia University Medical Center and panelists Michael Jaff, DO, from Massachusetts General Hospital; David Cohen, MD, from Saint Luke’s Mid America Heart Institute; and Mark Burket, MD, University of Toledo Medical Center for a panel discussion entitled, The Balance of Clinical Excellence and Cost-Effectiveness in Interventional Cardiology: Today and Tomorrow.

“The health care system today, more than ever, needs new, innovative solutions that will allow providers to deliver great patient care while being fiscally prudent,” said Don Casey, CEO, Cardinal Health Medical segment. “We believe there is an opportunity to build new solutions that combine product, services and analytics to bring more value to our customers.”

On the TCT show floor at booth #1233, Cardinal Health will be presenting its Interventional Solutions sets that help optimize interventional health care, including:

  • Operational efficiency - ensuring the right product in the right place at the right time from point of order to point of care.
  • Product quality - offering high quality, cost-effective products from basic essentials to complex procedures to promote excellent patient care.
  • Smart analytics - transforming data into actionable clinical, operational and financial insights.

For more information about these Cardinal Health solutions, visit http://cardinalhealth.com/interventional.

TCT is the world’s largest educational meeting specializing in interventional cardiovascular medicine, showcasing the latest advances in current therapies and clinical research. The event is being held at the Walter E. Washington Convention Center in Washington, D.C., Sept. 13 – 17.

About Cardinal Health
Headquartered in Dublin, Ohio, Cardinal Health, Inc. (NYSE: CAH) is a $91 billion health care services company that improves the cost-effectiveness of health care. As the business behind health care, Cardinal Health helps pharmacies, hospitals, ambulatory surgery centers, clinical laboratories and physician offices focus on patient care while reducing costs, enhancing efficiency and improving quality. Cardinal Health is an essential link in the health care supply chain, providing pharmaceuticals and medical products and services to more than 100,000 locations each day and is also the industry-leading direct-to-home medical supplies distributor. The company is a leading manufacturer of medical and surgical products, including gloves, surgical apparel and fluid management products. In addition, the company operates the nation's largest network of radiopharmacies that dispense products to aid in the early diagnosis and treatment of disease. Ranked #22 on the Fortune 500, Cardinal Health employs 34,000 people worldwide. More information about the company may be found at www.cardinalhealth.com and @CardinalHealth on Twitter.

More Company News
11/20/2024

Next generation of the Kendall™ SCD Series delivers an all-in-one solution for deep vein thrombosis and pulmonary embolism prevention DUBLIN, Ohio, Nov. 20, 2024 /PRNewswire/ -- Cardinal Health...

11/11/2024

Acquisition of a majority stake in GI Alliance, the country's leading gastroenterology management services organization, to accelerate Cardinal Health's multi-specialty growth strategy Acquisition...

11/05/2024

Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved a quarterly dividend of $0.5056 per share out of the Company's capital surplus. The dividend will be payable on...

11/01/2024

Revenue decreased 4% to $52.3 billion; revenue increased 15% excluding the impact of the previously communicated large customer contract expiration GAAP1 operating earnings were $568 million; GAAP...

View all company news »